S21I (p.Ser21Ile) variant of CEBPA (P49715)
S21I (p.Ser21Ile) in CEBPA (P49715) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Inborn genetic diseases; Acute myeloid leukemia. The available variant effect predictions contribute to a CATVariant prioritization score of 0.29 / 1. The record also includes population frequency data, published literature, and structural context.
S21I (p.Ser21Ile) variant details
- p.Ser21Ile
- rs890855027
- ClinGen CA307844453
- ClinVar RCV001352067
- ClinVar RCV004978396
- Uncertain significance
- Inborn genetic diseases; Acute myeloid leukemia
- Missense
- Variant Prioritization Score for Impact Estimate 0.288
- REVEL 0.08
- MetaLR 0.06
- MetaSVM -1.07
- CADD 22.00
- PolyPhen-2 0.04
- SIFT 0.18
- ClinVar: Uncertain significance (Inborn genetic diseases; Acute myeloid leukemia)
- EBI: Variant of uncertain significance
- UniProt: Uncertain significance
- Most common in the Non-Finnish European population (allele frequency 1.5e-05)
- Structural context available
- Cited in: CEBPA-Associated Familial Acute Myeloid Leukemia (AML). (PMID 20963938)
- Cited in: NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology. (PMID 22138009)